Blood pressure, heart rate and energy expenditure effects of the drug mirabegron.

Completed

• Conditions: Obesity; Metabolic and Endocrine - Metabolic disorders; Diet and Nutrition - Obesity

• Registration Number: ACTRN12617000542392
• Lead Sponsor: Baker Heart and Diabetes Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-04-18
• Last Update Posted: 15 July 2019

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Aged 18 – 40 years
- Not currently taking any prescription medications or other supplements or medications known to alter cardiovascular parameters or increase energy expenditure (as assessed by the study physician during medical screening)
- No history of major illness (as assessed by the study physician during medical screening)
- BMI equal to or less than 30 kg/m^2

Exclusion Criteria

- Hypertension (resting supine blood pressure greater than 140/90 mmHg)
- Pregnancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified